Through the production of important cytokines like IL-4, IL-10 and IFN-γ, the strategic design of multi-neoepitope anti-cancer vaccines employing neoantigenic epitopes shows promise in generating strong immune responses that these data are summarized in Table 1 and further detailed in Supplementary Table S3. This evidence concerns the gene IL10 and cancer.